The authors reported that bestatin can increase radiation-induced apoptosis by inhibiting APN/CD13 activity [96], and may therefore be proposed as a promising therapeutic approach to increase the efficacy of radiotherapy in cancers. The gene discussed is ANPEP; the disease is cancer.